FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases
The FDA reported that six patients died after being injected with Teva’s Copaxone or Sandoz’s Glatopa.
The FDA reported that six patients died after being injected with Teva’s Copaxone or Sandoz’s Glatopa.
What's Your Reaction?
